Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eargo, Inc.
  6. News
  7. Summary
    EAR   US2700871096

EARGO, INC.

(EAR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

The Law Offices of Frank R. Cruz : Continues Investigation of Eargo, Inc. (EAR) on Behalf of Investors

09/25/2021 | 12:06pm EDT

The Law Offices of Frank R. Cruz continues its investigation of Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On September 22, 2021, after the market closed, Eargo revealed that “it is the target of a criminal investigation by the U.S. Department of Justice (the ‘DOJ’) related to insurance reimbursement claims the Company has submitted on behalf of customers covered by federal employee health plans.” Moreover, the DOJ is the “principal contact related to the subject matter of the [ongoing] audit” of Eargo by an insurance company that is the Company’s largest third-party payor. As a result, Eargo withdrew its full year financial guidance.

On this news, the Company’s share price fell as much as 68% during intraday trading on September 23, 2021, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Eargo securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


ę Business Wire 2021
All news about EARGO, INC.
10/26ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Eargo, Inc. Investors with Losses to Sec..
PR
10/25SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors Eargo, I..
PR
10/20EARGO : The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action..
PR
10/20INVESTOR ALERT : Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Bee..
BU
10/19EARGO (EAR) INVESTORS : December 6, 2021 Filing Deadline in Class Action – Contact L..
BU
10/18EARGO : EAR Investors Have Opportunity to Lead Eargo, Inc. Securities Fraud Lawsuit
PR
10/17EARGO : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eargo, Inc. Investors With Losses to Se..
BU
10/15SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors Eargo, I..
PR
10/15EARGO : ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eargo, Inc. Investors With Losses Over..
PR
10/15EAR SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Notifies Eargo, Inc. Shareholde..
BU
More news
Analyst Recommendations on EARGO, INC.
More recommendations
Financials (USD)
Sales 2021 86,6 M - -
Net income 2021 - - -
Net cash 2021 169 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 317 M 317 M -
EV / Sales 2021 1,72x
EV / Sales 2022 1,72x
Nbr of Employees 238
Free-Float 86,4%
Chart EARGO, INC.
Duration : Period :
Eargo, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EARGO, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 8,08 $
Average target price 10,50 $
Spread / Average Target 30,0%
EPS Revisions
Managers and Directors
Christian Gormsen President, Chief Executive Officer & Director
Adam Laponis Chief Financial Officer
Joshua Makower Non-Executive Chairman
Daniel Shen Chief Clinical & Science Officer
Fernando Cruz Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
EARGO, INC.-81.55%325
THERMO FISHER SCIENTIFIC30.48%239 332
DANAHER CORPORATION37.80%219 325
INTUITIVE SURGICAL, INC.27.87%124 568
SIEMENS HEALTHINEERS AG42.35%77 688
EDWARDS LIFESCIENCES CORPORATION28.58%72 923